부산대학교 도서관

Singh S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Bradford D; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Li X; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Mishra-Kalyani PS; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Shen YL; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Wang L; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhao H; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Xiong Y; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Liu J; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Charlab R; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Kraft J; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Khasar S; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Miller CP; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Rivera DR; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Kluetz PG; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Pazdur R; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Beaver JA; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Singh H; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Donoghue M; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Barbato MI; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Nashed J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Bradford D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Ren Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Khasar S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Miller CP; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zolnik BS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhao H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Li Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Bi Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Shord SS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Amatya AK; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Mishra-Kalyani PS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Scepura B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Al-Matari RA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Kluetz PG; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Donoghue M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Singh H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland.; Drezner N; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Casey D; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Demko S; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Sinha A; Office of Biostatistics, FDA, Silver Spring, Maryland.; Mishra-Kalyani PS; Office of Biostatistics, FDA, Silver Spring, Maryland.; Shen YL; Office of Biostatistics, FDA, Silver Spring, Maryland.; Khasar S; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Goheer MA; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Helms WS; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Pan L; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Xu Y; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Fan J; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Leong R; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Liu J; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Yang Y; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Windsor K; Office of Pharmaceutical Quality, FDA, Silver Spring, Maryland.; Ou M; Office of Pharmaceutical Quality, FDA, Silver Spring, Maryland.; Stephens O; Office of Pharmaceutical Quality, FDA, Silver Spring, Maryland.; Oh B; Office of Pharmaceutical Quality, FDA, Silver Spring, Maryland.; Reaman GH; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Nair A; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Shord SS; Office of Clinical Pharmacology, FDA, Silver Spring, Maryland.; Bhatnagar V; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Daniels SR; Division of Clinical Outcome Assessment, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland.; Sickafuse S; Office of Oncologic Diseases, FDA, Silver Spring, Maryland.; Goldberg KB; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Theoret MR; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Pazdur R; Oncology Center of Excellence, FDA, Silver Spring, Maryland.; Singh H; Office of Oncologic Diseases, FDA, Silver Spring, Maryland. Bonnie.Singh@fda.hhs.gov.; Oncology Center of Excellence, FDA, Silver Spring, Maryland.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Marcus L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. leigh.marcus@fda.hhs.gov.; Lemery SJ; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Khasar S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Wearne E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Helms WS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Yuan W; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; He K; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Cao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Yu J; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Zhao H; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Wang Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Stephens O; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Englund E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Agarwal R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Keegan P; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.; Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Dina, O. A.; Khasar, S. G.; Gear, R. W.; Levine, J. D.

NEUROSCIENCE; MAY 5 2009, 160 2, p501-p507, 7p.

Casak SJ; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland. Sandra.Casak@fda.hhs.gov.; Fashoyin-Aje I; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.; Lemery SJ; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhang L; Office of Clinical Pharmacology, U.S. Food and Drug Administration, Silver Spring, Maryland.; Jin R; Office of Clinical Pharmacology, U.S. Food and Drug Administration, Silver Spring, Maryland.; Li H; Office of Clinical Pharmacology, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhao L; Office of Clinical Pharmacology, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhao H; Office of Clinical Pharmacology, U.S. Food and Drug Administration, Silver Spring, Maryland.; Zhang H; Office of Biostatistics, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland.; Chen H; Office of Biostatistics, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland.; He K; Office of Biostatistics, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland.; Dougherty M; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Novak R; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Kennett S; Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland.; Khasar S; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.; Helms W; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.; Keegan P; Office of Hematology and Oncology Products, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, Maryland.; Pazdur R; Office of Biostatistics, Office of Translational Sciences, U.S. Food and Drug Administration, Silver Spring, Maryland.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Shin, J; Cho, H; Hwang, SW; Jung, J; Shin, CY; Lee, SY; Kim, SH; Lee, MG; Choi, YH; Kim, J; Haber, NA; Reichling, DB; Khasar, S; Levine, JD; Oh, U

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA; JUL 23 2002, 99 15, p10150-p10155, 6p.

Khasar, Sachia G.; Burkham, Jennifer; Dina, Olayinka A.; Brown, Adrienne S.; Bogen, Oliver; Alessandri-Haber, Nicole; Green, Paul G.; Reichling, David B.; Levine, Jon D.

Journal of Neuroscience; 5/28/2008, Vol. 28 Issue 22, p5721-5730, 10p, 1 Chart, 6 Graphs

Khasar, S. G.; Reichling, D. B.; Green, P. G.; Isenberg, W. M.; Levine, J. D.

Neuroscience. Jun2003, Vol. 119 Issue 1, p215. 7p.

Khasar, S. G.; Gold, M. S.; Levine, J. D.

Neuroscience Letters; 1998, Vol. 256 Issue: 1 p17-20, 4p